Zobrazeno 1 - 10
of 1 269
pro vyhledávání: '"opioid agonist treatment"'
Publikováno v:
Harm Reduction Journal, Vol 21, Iss 1, Pp 1-10 (2024)
Abstract Background Understanding the heterogeneity of opioid overdose fatalities is critical to developing effective preventive interventions. This study examines patterns of care contacts among people who subsequently died from opioid overdose. The
Externí odkaz:
https://doaj.org/article/faa7da01836e40a6bbf88500c7b8bf05
Autor:
Mélanie Pinhal, Benoit Schreck, Juliette Leboucher, STIGMA-group, Caroline Victorri-Vigneau, Edouard-Jules Laforgue, Marie Grall-Bronnec
Publikováno v:
Addiction Science & Clinical Practice, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Background In the context of the opioid overdose crisis, understanding the barriers to seeking, attaining and remaining in treatment for patients with opioid use disorder (OUD) is a public health issue. To date, very few studies have assesse
Externí odkaz:
https://doaj.org/article/1b5e34be166f4352906bb668f6e86cf3
Autor:
Webster, Russell, Fearns, Colin, Harriott, Paula, Millar, Lisa, Simpson, Jardine, Wallace, Jason, Wheatley, Michael
Publikováno v:
International Journal of Prison Health, 2023, Vol. 20, Issue 2, pp. 143-155.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/IJOPH-05-2023-0025
Autor:
John Todd-Kvam, Thomas Clausen
Publikováno v:
Addiction Science & Clinical Practice, Vol 19, Iss 1, Pp 1-14 (2024)
Abstract Background Norway has a growing proportion of ageing opioid agonist treatment (OAT) patients, with 42% of the 8300 Norwegian OAT patients aged over 50 in 2022. This study aims to explore practitioners’ views and experiences from treatment
Externí odkaz:
https://doaj.org/article/68b39e4695d84e7aa2ffbe1229000aa6
Publikováno v:
Addiction Science & Clinical Practice, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Background Knowledge of co-occurring mental disorders (termed ‘dual diagnosis’) among patients receiving opioid agonist treatment (OAT) is scarce. This study aimed (1) to estimate the prevalence and structure of dual diagnoses in two nat
Externí odkaz:
https://doaj.org/article/310d9b23dc4341008ae3f87572077137
Autor:
Karl Trygve Druckrey-Fiskaaen, Jørn Henrik Vold, Tesfaye Madebo, Håvard Midgard, Olav Dalgard, Rafael Alexander Leiva, Lars T. Fadnes, for the INTRO-HCV Study Group
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy, Vol 19, Iss 1, Pp 1-11 (2024)
Abstract Background Persons with opioid use disorders (OUD) and persons with substance use disorders (SUD) who inject substances have a reduced life expectancy of up to 25 years compared with the general population. Chronic liver diseases are a subst
Externí odkaz:
https://doaj.org/article/d694804c641d46cd8db40f37ed00b3e0
Autor:
Sunsha Chamakalayil, Rudolf Stohler, Andreas Moldovanyi, Markus Gerber, Serge Brand, Kenneth M. Dürsteler
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
IntroductionThe first-line treatment for opioid dependence is opioid agonist treatment (OAT) with oral opioids. However, in some cases, treatment with intravenous diacetylmorphine (IV-DAM) is indicated. Research on neurocognitive impairments and trea
Externí odkaz:
https://doaj.org/article/034cd4f2ba3a4bd981bd99c834e0188e
Autor:
Scott Beaumont, Tianna Magel, Scott MacDonald, Scott Harrison, Martin Schechter, Eugenia Oviedo-Joekes
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy, Vol 19, Iss 1, Pp 1-11 (2024)
Abstract Background Across different types of oral Opioid Agonist Treatment for people with Opioid Use Disorder, receiving a dose that meets their needs is associated with better outcomes. Evidence also shows patients are more likely to receive an
Externí odkaz:
https://doaj.org/article/b7797b85aabb459fa683ecdff282ca3f
Autor:
Karl Trygve Druckrey-Fiskaaen, Tesfaye Madebo, Jan Tore Daltveit, Jørn Henrik Vold, Einar Furulund, Torgeir Gilje Lid, Lars Thore Fadnes
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-6 (2024)
Abstract This protocol paper presents an updated statistical analysis plan of the protocol of a randomised controlled trial. The randomised controlled trial investigates the effect of integrating smoking cessation interventions at outpatient opioid a
Externí odkaz:
https://doaj.org/article/f534597e046f4fd1b31a776221d12240
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy, Vol 18, Iss 1, Pp 1-16 (2023)
Abstract Background Ontario has one of the highest rates of substance-related harms in Canada. Residential treatment programs in the province provide a variety of in-house treatment services to support the needs of individuals with substance use diso
Externí odkaz:
https://doaj.org/article/db3840fcf2a9435dbea21d12dbec0c71